14 citations,
August 2020 in “Dermatologic Therapy” Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.
9 citations,
October 2020 in “Journal of The American Academy of Dermatology” Low-dose oral minoxidil is an effective and well-tolerated treatment for hair growth in alopecia patients.
6 citations,
April 2022 in “Journal of The American Academy of Dermatology” Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.
4 citations,
February 2022 in “JAAD case reports” The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.
2 citations,
January 2022 in “Skin appendage disorders” Low-dose oral minoxidil effectively promotes hair growth but has associated risks.
1 citations,
August 2022 in “Journal of Dermatological Treatment” 1 citations,
January 2020 in “Surgical & Cosmetic Dermatology” August 2023 in “JAAD International” Low dose oral minoxidil is generally safe and can improve hair loss in women, with some experiencing side effects and minimal blood pressure changes.
September 2024 in “Journal of the American Academy of Dermatology” Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.
August 2024 in “Archives of Dermatological Research” Low-dose oral minoxidil is effective and safe for treating androgenetic alopecia.
August 2024 in “Skin Research and Technology” July 2024 in “Skin Appendage Disorders” Low dose oral minoxidil is safe for treating hair loss in men.
March 2024 in “Journal of the American Academy of Dermatology” March 2024 in “Journal of the American Academy of Dermatology” October 2023 in “Journal of The American Academy of Dermatology” Taking a small dose of the hair growth medicine minoxidil by mouth does not really change your blood pressure.
September 2023 in “Journal of The American Academy of Dermatology” Low-dose oral minoxidil may be effective for hair loss treatment.
July 2023 in “Dermatology practical & conceptual” Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.
December 2022 in “PubMed” February 2023 in “International Journal of Dermatology” January 2023 in “Clinical and Experimental Dermatology” September 2022 in “Chinese Journal of Dermatology” August 2022 in “Journal of The European Academy of Dermatology and Venereology” August 2022 in “Journal of The American Academy of Dermatology” A 5-mg dose of oral minoxidil slightly lowers blood pressure temporarily, especially in those with higher initial blood pressure.
April 2022 in “Actas Dermo-Sifiliográficas” 10 citations,
January 2019 in “Indian Journal of Dermatology” Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.
2 citations,
March 2022 in “Journal of The European Academy of Dermatology and Venereology” September 2024 in “Archives of Dermatological Research” This study compared the efficacy and safety of low-dose oral minoxidil (LDOM) combined with either spironolactone or finasteride/dutasteride in treating female androgenetic alopecia (AGA). Both combination therapies showed similar improvements in hair growth and had comparable safety profiles. Although the group using LDOM with finasteride/dutasteride experienced a greater average increase in hair width and density, these differences were not statistically significant. The findings support the use of LDOM with either spironolactone or finasteride/dutasteride for female AGA and highlight the need for further research to confirm these results and evaluate long-term outcomes.
August 2024 in “Journal of Investigative Dermatology” July 2022 in “British Journal of Dermatology”